Theravance Biopharma Inc (TBPH) stock news · $861.5M cap
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
This TBPH news page leads with what Theravance Biopharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for TBPH yet. We will not pad this page with generic market recap.
Latest reported TBPH revenue for 2026-06-30 was $20.7M. Net income was -$5.9M. Revenue was up 17.1% from 2026-03-31 to 2026-06-30. TBPH currently screens at market cap $861.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TBPH stock page; for the tape open the quote page.
TBPH stock news FAQ
What are TBPH's latest revenue and net income?
Latest cached Theravance Biopharma Inc (TBPH) revenue for Jun 30, 2026 was $20.7M. Net income was -$5.9M. Statements: https://lician.com/financials/tbph
How did TBPH revenue change from the prior cached period?
Cached Theravance Biopharma Inc (TBPH) revenue was up 17.1% from $17.7M (Mar 31, 2026) to $20.7M (Jun 30, 2026). Statements: https://lician.com/financials/tbph
What is TBPH's market cap?
Theravance Biopharma Inc (TBPH) market cap is $861.5M on the latest cached fundamentals snapshot.
What kind of company is TBPH?
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Where is TBPH stock news listed?
Cached stock news for Theravance Biopharma Inc (TBPH) is listed at https://lician.com/news/tbph. Filings: https://lician.com/sec/tbph
Not investment advice.